Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV-Reference-Cited by-同舟云学术

Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV

Published:2020-09-09 Issue:3 Volume:43 Page:e388-e394
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Montgomery-Goecker Crystal,Koduru Prasad,Botten Giovanni,Xu Jian,Ghisoli Maurizio,Goldman Stanton C.,Krueger JoEllen,Bhushan Vikas,Fuda Franklin,Chen Weina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference28 articles.

1. The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review;Fisher;Histopathology,2014

2. EWS-ETS oncoproteins: the linchpins of Ewing tumors;Janknecht;Gene,2005

3. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities;Noujaim;Br J Cancer,2017

4. EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway;Endo;Cancer Sci,2016

5. Pre-B-cell acute lymphoblastic leukemia with bulk extramedullary disease and chromosome 22 (EWSR1) rearrangement masquerading as Ewing sarcoma;Jakovljevic;Pediatr Blood Cancer,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation;British Journal of Haematology;2024-02-22

2. Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype;Leukemia Research Reports;2024

3. Gene partners of the EWSR1 fusion may represent molecularly distinct entities;Translational Oncology;2023-12

4. Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature;Annals of Diagnostic Pathology;2022-06

5. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation;Cellular and Molecular Life Sciences;2022-02-28